Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 4
Results: 16
Editorial Board: Arch Pharm (4/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202370008
- Publication type:
- Article
Cover Picture: Arch Pharm (4/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202370007
- Publication type:
- Article
Design and synthesis of novel quinazolin‐4(1H)‐one derivatives as potent and selective inhibitors targeting AKR1B1.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200577
- By:
- Publication type:
- Article
Anticryptococcal activity and mechanistic studies of short amphipathic peptides.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200576
- By:
- Publication type:
- Article
A new series of hydrazones as small‐molecule aldose reductase inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200570
- By:
- Publication type:
- Article
Artemisinin‐isatin hybrids tethered via ethylene linker and their anti‐lung cancer activity.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200563
- By:
- Publication type:
- Article
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018–2022).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200562
- By:
- Publication type:
- Article
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200554
- By:
- Publication type:
- Article
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200545
- By:
- Publication type:
- Article
Thermodynamic characterization of a macrocyclic Zika virus NS2B/NS3 protease inhibitor and its acyclic analogs.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200518
- By:
- Publication type:
- Article
Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward hCA IX/XII, facilitating anticancer drug development.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200508
- By:
- Publication type:
- Article
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200486
- By:
- Publication type:
- Article
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200472
- By:
- Publication type:
- Article
Influence of the pK<sub>a</sub> value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200470
- By:
- Publication type:
- Article
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF<sup>V600E</sup> with promising antiproliferative properties.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200464
- By:
- Publication type:
- Article
Structure–activity relationship study to improve cytotoxicity and selectivity of lonafarnib against breast cancer cells.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 4, p. 1, doi. 10.1002/ardp.202200263
- By:
- Publication type:
- Article